The study, published in the Oct. 2011 issue of Anesthesia & Analgesia, found that neither the duration of anesthesia nor the time measured with the bispectral index under 45 are associated with the risk of new malignant disease within five years.
Maj-Lis Lindholm, PhD, from the Karolinska Institutet in Stockholm, Sweden, and colleagues investigated whether patients were diagnosed with cancer within five years of surgery. The risk of cancer during follow-up in relation to duration of anesthesia and time measured with the bispectral index under 45 were assessed, and then compared to the incidence of cancer in the standardized general population.
No correlation was found between duration of anesthesia or time measured with the bispectral index under 45 and new malignant disease. According to the author, neither factor was associated with increased risk for new malignant disease within five years of surgery in previously cancer-free patients.
Related Articles on Anesthesia:
Washington Surgeon Suspended Over Patient Death From Anesthetic
University of Virginia’s Pain Center Continues Pioneering Tradition
Anesthesiologist Dr. David Dugan Joins Board of Kansas’ Providence Medical Center
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
